Atalanta Sosnoff Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$37.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.4M |
| 3 |
Martin Marietta Materials
MLM
|
+$26.5M |
| 4 |
EA
Electronic Arts
EA
|
+$26.3M |
| 5 |
Zoetis
ZTS
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$45.3M |
| 2 |
American Tower
AMT
|
+$43.3M |
| 3 |
AGN
Allergan plc
AGN
|
+$38.7M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$34.8M |
| 5 |
Honeywell
HON
|
+$32.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.45% |
| 2 | Communication Services | 17.7% |
| 3 | Technology | 12.61% |
| 4 | Healthcare | 11.89% |
| 5 | Industrials | 10.74% |
Similar funds
Atalanta Sosnoff Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Atalanta Sosnoff Capital held 115 positions worth $2.81B, down 2.7% from $2.89B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Atalanta Sosnoff Capital withdrew a net $213M in Q4 2016, closing 13 positions and reducing 54 holdings. Its most notable exit was Zimmer Biomet, an estimated $45.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 14% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Atalanta Sosnoff Capital opened a new position in Bristol-Myers Squibb worth $30.4M.
- Atalanta Sosnoff Capital's largest Q4 2016 buy was Bristol-Myers Squibb: 520,169 shares worth $30.4M.
- Atalanta Sosnoff Capital added most to Chevron in Q4 2016, an estimated $37.9M increase.
- Atalanta Sosnoff Capital's biggest Q4 2016 reduction was American Tower, cutting an estimated $43.3M.
- Atalanta Sosnoff Capital fully exited Zimmer Biomet in Q4 2016, selling an estimated $45.3M.
- Atalanta Sosnoff Capital's ten largest holdings make up 33% of its $2.81B portfolio in Q4 2016.
- Atalanta Sosnoff Capital opened 9 new positions and closed 13 in Q4 2016.
- Atalanta Sosnoff Capital's portfolio value fell 2.7% quarter-over-quarter to $2.81B.
Based on Atalanta Sosnoff Capital's 13F filing for Q4 2016, filed 10 Jan 2017.